Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B.

CONCLUSIONS: rIX-FP extended interval prophylaxis provides dosing flexibility and, in selected patients, a 21-day regimen may provide an alternative option to minimize treatment burden and individualize treatment. PMID: 32078256 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32078256?dopt=Abstract

Source: Thrombosis and Haemostasis - February 19, 2020 Category: Hematology Authors: Mancuso ME, Lubetsky A, Pan-Petesch B, Lissitchkov T, Nagao A, Seifert W, Li Y, Santagostino E Tags: J Thromb Haemost Source Type: research